Search research articles
Contact Us
Filters
Showing results (221-230 of 1,257) with videos related to
Page
of 126
Sort By:
Biological Psychiatry
|
January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex
S R Hirsch, J de Belleroche
Chest
|
April 1, 1992
Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy
D R Hirsch, S Z Goldhaber
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1994
Clinical use of high-dose neuroleptics
S R Hirsch, T R Barnes
Drug Safety
|
May 1, 1993
Continuous versus intermittent neuroleptic therapy in schizophrenia
A G Jolley, S R Hirsch
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Incorporating the patient's voice in the continuum of care
Bradford R Hirsch, Amy P Abernethy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
The economics of new drugs: can we afford to make progress in a common disease?
Bradford R Hirsch, Kevin A Schulman
The Journal of Allergy and Clinical Immunology
|
December 1, 1972
Basophil degranulation: a new method of observation and its correlation with skin testing
S R Hirsch, J E Zastrow
Amino Acids
|
December 29, 2000
Amino acid transport in the renal proximal tubule
T Gonska, J R Hirsch, E Schlatter
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1991
Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction
R Hirsch, J Archibald, R E Gress
Journal of Abnormal Psychology
|
February 19, 2009
Looking on the bright side: accessing benign meanings reduces worry
Colette R Hirsch, Sarra Hayes, Andrew Mathews
Page
of 126
Search research articles
Search
Showing results (221-230 of 1,257) with videos related to
Sort By:
Page
of 126
Biological Psychiatry
|
January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex
S R Hirsch, J de Belleroche
Chest
|
April 1, 1992
Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy
D R Hirsch, S Z Goldhaber
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1994
Clinical use of high-dose neuroleptics
S R Hirsch, T R Barnes
Drug Safety
|
May 1, 1993
Continuous versus intermittent neuroleptic therapy in schizophrenia
A G Jolley, S R Hirsch
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Incorporating the patient's voice in the continuum of care
Bradford R Hirsch, Amy P Abernethy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
The economics of new drugs: can we afford to make progress in a common disease?
Bradford R Hirsch, Kevin A Schulman
The Journal of Allergy and Clinical Immunology
|
December 1, 1972
Basophil degranulation: a new method of observation and its correlation with skin testing
S R Hirsch, J E Zastrow
Amino Acids
|
December 29, 2000
Amino acid transport in the renal proximal tubule
T Gonska, J R Hirsch, E Schlatter
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1991
Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction
R Hirsch, J Archibald, R E Gress
Journal of Abnormal Psychology
|
February 19, 2009
Looking on the bright side: accessing benign meanings reduces worry
Colette R Hirsch, Sarra Hayes, Andrew Mathews
Page
of 126